Manufacturers Life Insurance Company, The Cin Cor Pharma, Inc. Transaction History

Manufacturers Life Insurance Company, The

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	N/A	-68,621 Closed	0 $0
Q4 2022 Aug 11, 2023	BUY	$10.75 - $29.84 $245,551 - $681,605	22,842 Added 49.9%	68,621 $843,000
Q4 2022 Feb 13, 2023	BUY	$10.75 - $29.84 $245,551 - $681,605	22,842 Added 49.9%	68,621 $843,000
Q3 2022 Aug 11, 2023	BUY	$19.9 - $38.94 $3,223 - $6,308	162 Added 0.36%	45,779 $1.28 Million
Q3 2022 Nov 03, 2022	BUY	$19.9 - $38.94 $3,223 - $6,308	162 Added 0.36%	45,779 $1.39 Million
Q2 2022 Aug 11, 2023	BUY	$13.67 - $25.74 $206,594 - $389,008	15,113 Added 49.54%	45,617 $859,000
Q2 2022 Aug 15, 2022	BUY	$13.67 - $25.74 $206,594 - $389,008	15,113 Added 49.54%	45,617 $766,000
Q1 2022 Aug 11, 2023	BUY	$14.13 - $28.49 $431,021 - $869,058	30,504 New	30,504 $535,000
Q1 2022 May 20, 2022	BUY	$14.13 - $28.49 $431,021 - $869,058	30,504 New	30,504 $568,000

Ticker CINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,764,300
Description
CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.